- Book
- September 2022
- 480 Pages
- Book
- September 2022
- 304 Pages
- Book
- December 2019
- 432 Pages
- Book
- December 2019
- 432 Pages
- Book
- April 2019
- 328 Pages
- Book
- January 2019
- 600 Pages
- Book
- March 2018
- 112 Pages
- Book
- May 2014
- 560 Pages
- Book
- February 2011
- 488 Pages
- Book
- January 2017
- 488 Pages
- Book
- January 2016
- 952 Pages
- Book
- April 2014
- 344 Pages
- Book
- April 2013
- 296 Pages
- Book
- November 2012
- 240 Pages
- Book
- April 2012
- 776 Pages
- Book
- November 2011
- 432 Pages
- Book
- April 2011
- 248 Pages
Global
- Book
- March 2011
- 268 Pages
- Book
- November 2010
- 232 Pages
- Book
- April 2009
- 120 Pages

Thrombosis is a medical condition in which a blood clot forms in a blood vessel, obstructing the flow of blood. It is a major concern in hematology, as it can lead to serious complications such as stroke, heart attack, and pulmonary embolism. Treatment of thrombosis typically involves anticoagulants, which are drugs that reduce the ability of the blood to clot. In some cases, thrombolytic drugs may be used to dissolve the clot.
The thrombosis market is a rapidly growing segment of the hematology market, driven by the increasing prevalence of thrombosis and the development of new treatments. The market is expected to benefit from the introduction of novel drugs and therapies, as well as the increasing demand for better diagnosis and treatment of thrombosis.
Some of the major companies in the thrombosis market include Bayer AG, Pfizer Inc., Sanofi, Bristol-Myers Squibb, and Johnson & Johnson. Show Less Read more